Emergence and prevalence of β-lactamase-producing Klebsiella pneumoniae resistant to cephems in Japan

International Journal of Antimicrobial Agents

Volumn 27, Issue 6, 2006, Pages 491-499

  Muratani, Tetsuro ^a,b   Kobayashi, Tomoko ^b   Matsumoto, Tetsuro ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b Hibiki Research Group for Clinical Microbiology   (Japan)

Author keywords

DHA 1 lactamase; Extended spectrum lactamase; Klebsiella pneumoniae; Plasmid mediated Class C lactamase

Indexed keywords

ANTIBIOTIC AGENT; AZTREONAM; BETA LACTAMASE; BETA LACTAMASE AMPC; CEFMETAZOLE; CEFOTAXIME; CEFOXITIN; CEFPIROME; CEFPODOXIME; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CEPHAMYCIN DERIVATIVE; CEPHEM; CLAVULANIC ACID; DNA; EXTENDED SPECTRUM BETA LACTAMASE; IMIPENEM; INOSINE PHOSPHATE; LATAMOXEF; PIPERACILLIN; RIFAMPICIN; SHV 27; TAZOBACTAM; THIOLACTIC ACID; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; ENZYME SYNTHESIS; GENE IDENTIFICATION; GENE STRUCTURE; HOSPITAL INFECTION; ISOELECTRIC FOCUSING; JAPAN; KLEBSIELLA PNEUMONIAE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; RESTRICTION FRAGMENT;

BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CEPHALOSPORINS; CEPHAMYCINS; CONJUGATION, GENETIC; ELECTROPHORESIS, GEL, PULSED-FIELD; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; PLASMIDS;

EID: 33646772846     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2006.03.007     Document Type: Article

References (18)

1. Knothe H., Shah P., Krcmery V., Antal M., and Mitsuhashi S. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection 11 (1983) 315-317
2. Papanicolaou G.A., Medeiros A.A., and Jacoby G.A. Novel plasmid-mediated beta-lactamase (MIR-1) conferring resistance to oxyimino- and alpha-methoxy beta-lactams in clinical isolates of Klebsiella pneumoniae. Antimicrob Agents Chemother 34 (1990) 2200-2209
3. Ishii Y., Ohno A., Taguchi H., Imajo S., Ishiguro M., and Matsuzawa H. Cloning and sequence of the gene encoding a cefotaxime-hydrolyzing class A beta-lactamase isolated from Escherichia coli. Antimicrob Agents Chemother 39 (1995) 2269-2275
4. Horii T., Arakawa Y., Ohta M., Ichiyama S., Wacharotayankun R., and Kato N. Plasmid-mediated AmpC-type beta-lactamase isolated from Klebsiella pneumoniae confers resistance to broad-spectrum beta-lactams, including moxalactam. Antimicrob Agents Chemother 37 (1993) 984-990
5. Osano E., Arakawa Y., Wacharotayankun R., et al. Molecular characterization of an enterobacterial metallo beta-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance. Antimicrob Agents Chemother 38 (1994) 71-78
6. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A5. 6th ed. (2003), NCCLS, Wayne, PA
7. Tenover F.C., Arbeit R.D., Goering R.V., et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33 (1995) 2233-2239
8. Livermore D.M., and Brown D.F. Detection of beta-lactamase-mediated resistance. J Antimicrob Chemother 48 Suppl. 1 (2001) 59-64
9. Barnaud G., Arlet G., Verdet C., Gaillot O., Lagrange P.H., and Philippon A. Salmonella enteritidis: AmpC plasmid-mediated inducible beta-lactamase (DHA-1) with an ampR gene from Morganella morganii. Antimicrob Agents Chemother 42 (1998) 2352-2358
10. Livermore D.M., and Yuan M. Antibiotic resistance and production of extended-spectrum beta-lactamases amongst Klebsiella spp. from intensive care units in Europe. J Antimicrob Chemother 38 (1996) 409-424
11. Bauernfeind A., Chong Y., and Lee K. Plasmid-encoded AmpC beta-lactamases: how far have we gone 10 years after the discovery?. Yonsei Med J 39 (1998) 520-525
12. Alvarez M., Tran J.H., Chow N., and Jacoby G.A. Epidemiology of conjugative plasmid-mediated AmpC beta-lactamases in the United States. Antimicrob Agents Chemother 48 (2004) 533-537
13. Bauernfeind A., Stemplinger I., Jungwirth R., and Giamarellou H. Characterization of the plasmidic beta-lactamase CMY-2, which is responsible for cephamycin resistance. Antimicrob Agents Chemother 40 (1996) 221-224
14. Koeck J.L., Arlet G., Philippon A., et al. A plasmid-mediated CMY-2 beta-lactamase from an Algerian clinical isolate of Salmonella senftenberg. FEMS Microbiol Lett 152 (1997) 255-260
15. Yan J.J., Ko W.C., Wu H.M., Tsai S.H., Chuang C.L., and Wu J.J. Complexity of Klebsiella pneumoniae isolates resistant to both cephamycins and extended-spectrum cephalosporins at a teaching hospital in Taiwan. J Clin Microbiol 42 (2004) 5337-5340
16. Pai H., Kang C.I., Byeon J.H., et al. Epidemiology and clinical features of bloodstream infections caused by AmpC-type-beta-lactamase-producing Klebsiella pneumoniae. Antimicrob Agents Chemother 48 (2004) 3720-3728
17. Yan J.J., Ko W.C., Jung Y.C., Chuang C.L., and Wu J.J. Emergence of Klebsiella pneumoniae isolates producing inducible DHA-1 beta-lactamase in a university hospital in Taiwan. J Clin Microbiol 40 (2002) 3121-3126
18. Tran J.H., and Jacoby G.A. Mechanism of plasmid-mediated quinolone resistance. Proc Natl Acad Sci USA 99 (2002) 5638-5642